688443.SS
688443.SS
CNE100006KG8
CHONGQING GENRIX BIOPHARMACEUTI
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 230.726.830 30.094.961
666.7%
Cost of Revenue 16.093.662 5.309.828
203.1%
Gross Profit 214.633.167 24.785.133
766.0%
760.198.009 860.696.504
11.7%
Operating Income -545.564.842 -835.911.371
34.7%
Pretax Income -535.649.615 -797.273.630
32.8%
Net Income Common Stockholders -535.649.615 -797.273.630
32.8%
-- --
--
-- --
--
ende